A Study to Assess the Safety and Efficacy of AGN-151586 Injections for the Treatment of Moderate to Severe Forehead Lines (FHL) in Adult Participants

Part of paid clinical trials in Newport Beach, California.

Sponsor
AbbVie
Study ID
NCT07730554
Phase
PHASE2
Status
Recruiting
Apply to this trial

Conditions

  • Forehead Lines

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • AGN-151586 — DRUG
    Injection

Study Details

The objective of this study is to evaluate the safety and efficacy of AGN-151586 for the treatment of moderate to severe forehead lines (FHL) in adult participants.

Key Dates

First listed
Jul 28, 2026
Start date
Jul 22, 2026
Status verified
Aug 2026
Primary completion
Oct 31, 2026
Completion
Nov 30, 2026

Study Design

Enrollment
80 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Open-Label AGN-151586
    Participants will receive a single treatment of AGN-151586 on Day 1.

Primary Outcome Measure

Number of Participants with Adverse Events (AEs) [ Time Frame: Up to Approximately 42 Days ]

Central Contacts

Locations (5)

FacilityCityStateZIPSite coordinators
Eye Research Foundation /ID# 282193Newport BeachCalifornia92663-
Private Practice - Dr. Steven G. Yoelin /ID# 282334Newport BeachCalifornia92663-
Luxurgery /ID# 282336New YorkNew York10021-
Wilmington Dermatology Center /ID# 282192WilmingtonNorth Carolina28403-
Austin Institute for Clinical Research - Pflugerville /ID# 282195PflugervilleTexas78660-

Find similar trials in Newport Beach, CA

By research site
Eye Research Foundation· Newport Beach, CAPrivate Practice - Dr. Steven G. Yoelin· Newport Beach, CALuxurgery· New York, NYWilmington Dermatology Center· Wilmington, NCAustin Institute for Clinical Research - Pflugerville· Pflugerville, TX